Cardiac Ablation — Now in the iCMR

We have developed products for cardiac ablation procedures in the iCMR.

Learn More →

In His Own Words-Imricor's CEO Joins Equity Mates to Discuss Our Founding Story and What's Next

Image
Image

Uncovered: Read the Equity Mates Article Exploring Imricor's Story

Cardiac Ablation — Now in the iCMR

We have developed products for cardiac ablation procedures in the iCMR.

Learn More →

News & Press

Johns Hopkins Treats First Patient in the United States as Part of Imricor’s VISABL-AFL Clinical Trial

August 14, 2024

VISABL-AFL Trial for US FDA Approval Commences at Cardiovascular Institute of South Paris

June 21, 2024

Imricor Receives Approval from Saudi Food and Drug Authority

January 17, 2024
More news →

News & Press

Johns Hopkins Treats First Patient in the United States as Part of Imricor’s VISABL-AFL Clinical Trial

August 14, 2024

VISABL-AFL Trial for US FDA Approval Commences at Cardiovascular Institute of South Paris

June 21, 2024

Imricor Receives Approval from Saudi Food and Drug Authority

January 17, 2024
More news →

iCMR COMPATIBLE EP-RECORDER/ STIMULATOR

Advantage-MR EP Recorder / Stimulator

An Electrophysiology amplifier and recording system with integrated cardiac stimulator.
Learn more →

FIRST AND ONLY iCMR ABLATION CATHETER

Vision-MR Ablation Catheter

Patented ablation catheter to be used while a patient is being actively scanned in the iCMR.

Learn more →
We are extremely excited to offer this to our patients and to lead the way forward with this new approach.
Professor Gerhard Hindricks MD
Head of Rhythmology German Heart Center of the Charité

Imricor Presence Around the World

Image

Want to Learn More?

Get in Contact →